# Schistosoma Haematobium Infections and Praziquantel

> **NCT01558336** · PHASE3 · COMPLETED · sponsor: **University of Khartoum** · enrollment: 520 (actual)

## Conditions studied

- Schistosomiasis

## Interventions

- **DRUG:** praziquantel

## Key facts

- **NCT ID:** NCT01558336
- **Lead sponsor:** University of Khartoum
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2013-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01558336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01558336, "Schistosoma Haematobium Infections and Praziquantel". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01558336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*